Functional Genomics

Trugene Genotyping Technology Effective For Hepatitis B And C

Published in Hepatitis Weekly, January 21st, 2002

Visible Genetics, Inc., presented results of comparative studies using its Trugene hepatitis B virus (HBV) and hepatitis C virus (HCV) genotyping tests December 2001 at the Frontiers in Drug Development for Viral Hepatitis (HEP DART) conference held in Hawaii.

The results of one study demonstrated that the Trugene HBV Genotyping Kit reveals substantially more about the virus than other tests in common use. The second study confirmed that the Trugene HCV 5'NC Genotyping Kit is an accurate and reliable method for determining HCV genotype - a significant predictor of response to interferon therapy.

Visible Genetics' Trugene genotyping tests are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-01-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry